Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.
about
Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score-report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK).Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience
P2860
Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Multicenter, Phase 1, Dose Esc ...... ma and Anaplastic Astrocytoma.
@en
Multicenter, Phase 1, Dose Esc ...... ma and Anaplastic Astrocytoma.
@nl
type
label
Multicenter, Phase 1, Dose Esc ...... ma and Anaplastic Astrocytoma.
@en
Multicenter, Phase 1, Dose Esc ...... ma and Anaplastic Astrocytoma.
@nl
prefLabel
Multicenter, Phase 1, Dose Esc ...... ma and Anaplastic Astrocytoma.
@en
Multicenter, Phase 1, Dose Esc ...... ma and Anaplastic Astrocytoma.
@nl
P2093
P2860
P1476
Multicenter, Phase 1, Dose Esc ...... ma and Anaplastic Astrocytoma.
@en
P2093
Andrew B Lassman
Antonio Omuro
Ase Ballangrud
Elizabeth Neil
Igor Barani
Jennifer Clarke
Josh Yamada
Katherine S Panageas
Kathryn Beal
Philip Gutin
P2860
P304
P356
10.1016/J.IJROBP.2017.06.2466
P407
P577
2017-06-30T00:00:00Z